Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis

Recruiting N/A Interventional Study
Symptomatic Irreversible Pulpitis (SIP)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Dow University of Health Sciences · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
All Patients coming to the Operative Dentistry Department (DIDC-DUHS) with complain of pain in posterior teeth will be invited to participate. The treatment will be done by one dentist. Patient's medical and dental history will be recorded, and tooth will be checked for swelling, sensitivity, cavity type, and loosening of tooth. Special tests like the cold test, electric pulp test, and an X-ray wi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Teeth of generally healthy patients having following criteria will be included: 1. Age between 18-40 years of both males and females 2. Carious exposed maxillary and mandibular molars teeth 3. Moderate to severe pain (VAS 4-10) 4. Diagnosed with Symptomatic irreversible pulpiti…
Contacts

Dr Khadija Zubair, Postgraduate trainee- FCPS

03363605145

khadija.zubair21@yahoo.com

CONTACT